Alterations in the glutathione metabolism could be implicated in the ischemia-induced small intestinal cell damage in horses

BMC Veterinary Research

Volumn 5, Issue , 2009, Pages

  Marañón, Gonzalo ^a   Manley, William ^a   Cayado, Patricia ^a   García, Cruz ^b   de la Muela, Mercedes S ^b   Vara, Elena ^b  

^a Horsepital SL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

ADENOSINE TRIPHOSPHATE; CARBON MONOXIDE; GLUTATHIONE; METHIONINE ADENOSYLTRANSFERASE; METHYLTRANSFERASE; NITRIC OXIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CYTOLOGY; ENZYMOLOGY; HORSE; HORSE DISEASE; ISCHEMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SMALL INTESTINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARBON MONOXIDE; GLUTATHIONE; HORSE DISEASES; HORSES; INTESTINE, SMALL; ISCHEMIA; METHIONINE ADENOSYLTRANSFERASE; METHYLTRANSFERASES; NITRIC OXIDE;

EID: 64249171435     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-5-10     Document Type: Article

References (56)

1. Meyers K, Reed S, Keck M, Clem M, Bayly W. Circulating endotoxin-like substance(s) and altered hemostasis in horses with gastrointestinal disorders: an interim report. Am J Vet Res 1982, 43:2233-2238.
2. Welles EG, Prasse KW, Moore JN. Use of newly developed assays for protein C and plasminogen in horses with signs of colic. American Journal Of Veterinary Research 1991, 52(2):345-351.
3. Davis JL, Papich MG, Morton AJ, Gayle J, Blikslager AT, Campbell NB. Pharmacokinetics of etodolac in the horse following oral and intravenous administration. Journal Of Veterinary Pharmacology And Therapeutics 2007, 30(1):43-48.
4. Tschetter JR, Blikslager AT, Little D, Howard RD, Woody SL, Beex LM, Crisman MV. Detection of differentially regulated genes in ischaemic equine intestinal mucosa. Equine Veterinary Journal 2005, 37(4):319-324. 10.2746/0425164054529382, 16028620.
5. Moore R. Clinical relevance of intestinal reperfusion injury in horses. J Am Vet Med Assoc 1997, 211:1362-1366.
6. Sastre JPF, Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 2000, 49(5):427-435. 10.1080/152165400410281, 10902575.
7. Reiter RJTD, Cabrera J, D'Arpa D, Sainz RM, Mayo JC, Ramos S. The oxidant/antioxidant network: role of melatonin. Biol Signals and Recept 1999, 8:56-63.
8. Reiter R. Oxidative damage in the central nervous system: protection by melatonin. Progress in Neurobiology 1998, 56:359-384. 10.1016/S0301-0082(98)00052-5, 9770244.
9. Ryter SWOL, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002, 234-235:249-263.
10. Kaplovitz NOM. The regulation of hepatic glutathione. Annu Rev Toxicol 1985, 25:715-719.
11. Dröge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 2002, 37:1333-1345. 10.1016/S0531-5565(02)00175-4, 12559403.
12. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983, 52:711-713. 10.1146/annurev.bi.52.070183.003431, 6137189.
13. Weinberg JMDJA, Abarzua M, Rajan T. Cytoprotective effects of glycine and glutathione against hypoxia injury to renal tubes. J Clin Invest 1987, 80:1446-1454. 442402, 2890657, 10.1172/JCI113224.
14. Barcley LR. The cooperative antioxidant role of glutathione with lipid-solube and water-solube antioxidant during peroxidation of liposomes initiated in the aqueous phase and in the lipid phase. J Biol Chem 1988, 263:16138-16142.
15. Martesson J, Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc Natl Acad Sci USA 1989, 86:471-475. 286492, 2911592, 10.1073/pnas.86.2.471.
16. Martensson J, Jaint A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA 1990, 87:1715-1719. 53553, 2308931, 10.1073/pnas.87.5.1715.
17. Mato JMAL, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997, 73:265-280. 10.1016/S0163-7258(96)00197-0, 9175157.
18. Ko K, Yang H, Noureddin M, Iglesia-Ara A, Xia M, Wagner C, Luka Z, Mato JM, Lu SC. Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab Invest 2008, 88:1121-1129. 10.1038/labinvest.2008.69, 18695670.
19. Semmler A, Smulders Y, Struys E, Smith D, Moskau S, Blom H, Linnebank M. Methionine metabolism in an animal model of sepsis. Clin Chem Lab Med 2008, 46:1398-1402. 10.1515/CCLM.2008.277, 18844494.
20. White N. Examination and diagnosis of the acute abdomen. 1990, 102-142. Philadelphia: Lea & Febiger.
21. Owens CW, Belcher RV. A colorimetric micro-method for the determination of glutathione. Biochem J 1965, 94:705-711. 1206606, 14340062.
22. Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JAF. Effect of recombinant human growth hormone on age-related hepatocyte changes in old male and female wistar rats. Endocrine 2004, 25:33-39. 10.1385/ENDO:25:1:33, 15545704.
23. Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JAF. Effect of growth hormone and estrogen administration on hepatocyte alterations in old ovariectomized female wistar rats. Endocrine 2005, 26(1):11-18. 10.1385/ENDO:26:1:011, 15805580.
24. Cantoni G. S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind placebo-controlled study. Gastroenterology 1990, 99:211-215.
25. Duce AM, Ortíz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988, 8:65-68. 10.1002/hep.1840080113, 3338721.
26. Nosalova V, Navarova J, Mihalova D, Sotnikova R. Evaluation of the modulatory role of nimodipine in mesentreric ischaemia/reperfusion-induced intestinal and vascular damage effect of stobadine. Methods Find Exp Clin Pharmacol 2007, 29(1):39-43. 10.1358/mf.2007.29.1.1063495, 17344943.
27. Tribble D, Aw TY, Jones DP. The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 1987, 7:377-386. 10.1002/hep.1840070227, 3549510.
28. Jackman BR, Moore JN, Barton MH, Morris DD. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxemia. Can J Vet Res 1994, 58(2):138-143. 1263680, 8004539.
29. Boveris AAS, Navarro A. The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic Biol Med 2002, 339:1186-1193.
30. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003, 140-141:105-112.
31. Chung HY, Kim HJ, Kim KW, Choi JS, Yu BP. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc Res Tech 2002, 59:264-272. 10.1002/jemt.10203, 12424787.
32. Castillo CSV, Ariznavarreta C, Vara E, Tresguerres JA. Effect of recombinant human growth hormone on age-related hepatocyte changes in old male and female Wistar rats. Endocrine 2004, 25:33-39. 10.1385/ENDO:25:1:33, 15545704.
33. Barocelli E. The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide: Biology And Chemistry 2006, 14(3):212-218.
34. Fahey R, Sundquist AR. Evolution of glutathione metabolism. Adv Enzymol 1991, 64:1-53.
35. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free radical induced toxicity and glutathione-dependent protection. Pharmacol Ther 1988, 37:16138-16142.
36. Evans PJ, Whiteman M, Tredger JM, Halliwell B. Antioxidant properties of S-adenosyl-L-methionine: a proposed addition to organ storage fluids. Free Radic Biol Med 1997, 23:1002-1008. 10.1016/S0891-5849(97)00124-X, 9358243.
37. De La Cruz JPVM, Cuerda MA, Guerrero A, Gonzalez-Correa JA, Sanchez De La Cuesta F. Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation. Neurosci Lett 2002, 318:103-107. 10.1016/S0304-3940(01)02475-2, 11796196.
38. Arias-Diaz JVE, Garcia C, Villa N, Rodriguez JM, Ortiz P, Balibrea JL. S-adenosylmethionine protects hepatocytes against the effects of cytokines. J Surg Res 1996, 62:79-84. 10.1006/jsre.1996.0177, 8606515.
39. Avila MAG-TE, Martinez-Chantar ML, Latasa MU, Perez-Mato I, Martinez-Cruz LA, del Pino MM, Corrales FJ, Mato JM. S-Adenosylmethionine revisited: its essential role in the regulation of liver function. Alcohol 2002, 27:163-167. 10.1016/S0741-8329(02)00228-8, 12163144.
40. Lieber C. Role of S-adenosyl-L-methionine in the treatment of liver diseases. J Hepatol 1999, 30:1155-1159. 10.1016/S0168-8278(99)80274-8, 10406198.
41. Lieber C. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol 2002, 27:173-177. 10.1016/S0741-8329(02)00230-6, 12163146.
42. Mato JMCJ, Fernandez de Paz J, Caballeria L, Coll S, Caballero A, Garcia-Buey L, Beltran J, Benita V, Caballeria J, Sola R, Moreno-Otero R, Barrao F, Martin-Duce A, Correa JA, Pares A, Barrao E, Garcia-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rodes J. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999, 30:1081-1089. 10.1016/S0168-8278(99)80263-3, 10406187.
43. Frezza MCG, Cammareri G, Le Grazie C, Di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990, 37(Suppl 2):122-125.
44. Frezza MSC, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology 1990, 99:211-215.
45. Muriel PSO, Gonzalez P, Zuniga L. Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994, 21:95-102. 10.1016/S0168-8278(94)80143-6, 7963428.
46. Belli DC, Fournier LA, Lepage G, Yousef I, Roy CC. S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat. J Hepatol 1994, 21:18-23. 10.1016/S0168-8278(94)80131-2, 7963417.
47. Sanchez-Gongora ERF, Mingorance J, An W, Corrales FJ, Mato JM. Interaction of liver methionine adenosyltransferase with hydroxyl radical. FASEB J 1997, 11:1013-1019.
48. Avila MA, Corrales FJ, Ruiz F, Sanchez-Gongora E, Mingorance J, Carretero MV, Mato JM. Specific interaction of methionine adenosyltransferase with free radicals. Biofactors 1998, 8:27-32. 10.1002/biof.5520080106, 9699005.
49. Ruiz FCF, Miqueo C, Mato JM. Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation. Hepatology 1998, 28:1051-1057. 10.1002/hep.510280420, 9755242.
50. Corrales FOP, Rivas C, Martin-Lomas M, Mato JM, Pajares MA. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction. Hepatology 1991, 14:528-533.
51. Corrales F, Pajares MA, Ortiz P, Mato JM. Impairment of methionine metabolism in liver disease. Drug Investigation 1992, 4(Suppl 4):8-13.
52. Chawla RK, Jones DP. Abnormal metabolism of S-adenosyl-L-methionine in hypoxic rat liver. Similarities to its abnormal metabolism in alcoholic cirrhosis. Biochim Biophys Acta 1994, 1199:45-51. 8280752.
53. Baranano DE, Snyder SH. Neural roles for heme oxygenase: contrast to nitric oxide synthase. PNAS 2001, 98:10996-11002. 58673, 11572959, 10.1073/pnas.191351298.
54. Guo XSV, Cho CH. Modulation of heme oxagenase in tissue injury and its implication in protection against gastrointestinal diseases. Life Sci 2001, 69:3113-3119. 10.1016/S0024-3205(01)01417-5, 11758836.
55. Henningsson RAP, Lundquist I. Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia. Am J Physiol Cell Physiol 2001, 280:C1242-1254.
56. Otterbein LE, Bach FHAJ, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 2000, 6:422-428. 10.1038/74680, 10742149.